Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) EBIT Margin (2020 - 2025)

Cellebrite DI's EBIT Margin history spans 6 years, with the latest figure at 16.15% for Q4 2025.

  • Quarterly EBIT Margin rose 173.0% to 16.15% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 13.98% through Dec 2025, down 21.0% year-over-year, with the annual reading at 13.98% for FY2025, 21.0% down from the prior year.
  • EBIT Margin came in at 16.15% for Q4 2025, up from 15.07% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 18.2% in Q3 2024 to a low of 8.95% in Q2 2022.
  • The 5-year median for EBIT Margin is 12.07% (2025), against an average of 9.27%.
  • Year-over-year, EBIT Margin plummeted -2284bps in 2022 and then soared 1498bps in 2023.
  • Cellebrite DI's EBIT Margin stood at 6.34% in 2021, then soared by 106bps to 13.07% in 2022, then increased by 23bps to 16.13% in 2023, then fell by -11bps to 14.42% in 2024, then increased by 12bps to 16.15% in 2025.
  • Per Business Quant, the three most recent readings for CLBT's EBIT Margin are 16.15% (Q4 2025), 15.07% (Q3 2025), and 12.73% (Q2 2025).